Drug synergy of combinatory treatment with remdesivir and the repurposed drugs fluoxetine and itraconazole effectively impairs SARS-CoV-2 infection in vitro - Schloer, S; Brunotte, L; Mecate-Zambrano, A (Br J Pharmacol, 2021)
et al.